EPRONTIA™已被批准作为单一疗法,用于治疗2岁及以上患者的部分发作或原发性全身强直-阵挛发作;作为辅助疗法,用...查看全文
美港电讯APP2021-08-06 16:28
$Eton Pharmaceuticals(ETON)$ 盘前涨10.4%,美国食品药品监督管理局(FDA)今日将审核是否批准Eton Pharmaceuticals治疗癫痫的口服新药。(来自美港电讯APP)查看全文
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-005605 Size: 5 KB 网页链接
$Eton Pharmaceuticals(ETON)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001493152-22-002544 Act: 34 Size: 67 KB 网页链接
$Eton Pharmaceuticals(ETON)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-22-002088 Act: 34 Size: 88 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, item 8.01 Accession Number: 0001493152-21-032176 Act: 34 Size: 207 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-21-031988 Act: 34 Size: 251 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, item 8.01 Accession Number: 0001493152-21-031348 Act: 34 Size: 208 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-029375 Size: 5 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-029119 Size: 11 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-21-028848 Act: 34 Size: 5 MB 网页链接
$Eton Pharmaceuticals(ETON)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001493152-21-028835 Act: 34 Size: 29 KB 网页链接